Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas
Authors:
- Takuro WadaTWTakuro Wada
- Akira KawaiAKAkira Kawai
- Atsushi MakimotoAMAtsushi Makimoto
- Hirokazu ChumanHCHirokazu Chuman
- Yasuo BeppuYBYasuo Beppu
- Yoichi TaniYTYoichi Tani
- Tadashi HasegawaTHTadashi Hasegawa
Open Access
Abstract
BACKGROUND: Little is known about the expression of receptor tyrosine kinases in adult soft tissue sarcomas (STS). In the current study, the authors analyzed the expression of epidermal growth factor receptor (EGFR), ERBB2, and KIT in 281 patients with STS who were treated in a single institution. Verification of the presence of an association with prognosis was performed.METHODS: The current study included 281 adult patients with STS of the extremity and trunk who were diagnosed and treated in the National Cancer Center, Tokyo. Expression was assessed using immunohistochemical stains for EGFR, ERBB2, and KIT on formalin‐fixed, paraffin‐embedded tissue sections by standard avidin‐biotin peroxidase complex technique and EGFR detection system.RESULTS: Positive staining of EGFR was observed in 168 of 281 (60%) patients. Positive staining was common in pleomorphic malignant fibrous histiocytomas (89%), myxofibrosarcomas (89%), synovial sarcomas (76%), malignant peripheral nerve sheath tumors (89%), and leiomyosarcomas (73%). It was less common in well differentiated liposarcomas (38%), fibrosarcomas (36%), and myxoid liposarcomas (6%). In contrast, positive staining of ERBB2 and KIT was very limited. Increased levels of EGFR were significantly associated with a decreased probability of overall survival (P = 0.01), although by univariate analysis; probability of overall survival at 5 years was 64% in patients with increased levels of EGFR and 79% in patients without such overexpression. The overexpression of EGFR was significantly associated with histologic grade (P < 0.001). Moreover, stratified log‐rank test revealed that there is an interrelation between EGFR overexpression and histologic grade.CONCLUSIONS: EGFR overexpression was found to be a negative prognostic factor of adult STS, which is strongly associated with histologic grade. STS patients with EGFR overexpression may benefit from treatment with currently available biospecific inhibitors for EGFR. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 38 references indexed in Scilit:
- Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 casesJournal of Cancer Research and Clinical Oncology, 2002
- Epidermal growth factor receptor expression and measurement in solid tumorsSeminars in Oncology, 2002
- Molecular characterisation of soft tissue tumours: a gene expression studyThe Lancet, 2002
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998
- HER-2/neu Expression in Pancreatic AdenocarcinomaPancreas, 1997
- Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor functionCell, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- LiposarcomasAmerican Journal of Surgical Pathology, 1984